SDMA & Kidney Disease: Early Detection Guide¶
SDMA (symmetric dimethylarginine) is the cornerstone of early kidney-disease detection in dogs and cats. This page explains why it outperforms creatinine as an early marker and how to use it for IRIS staging.
Why SDMA Beats Creatinine for Early Detection¶
| Attribute | SDMA | Creatinine |
|---|---|---|
| Rises at GFR loss | ~40% | ~75% |
| Affected by muscle mass | No | Yes |
| Affected by diet | No | Mildly |
Creatinine rises only after substantial kidney damage; SDMA rises much earlier — enabling detection when intervention can still change the course.
IRIS CKD Staging¶
SDMA contributes to IRIS staging of chronic kidney disease:
| IRIS Stage | SDMA (µg/dL) |
|---|---|
| Stage 1 | < 18 |
| Stage 2 | 18–35 |
| Stage 3 | 36–54 |
| Stage 4 | > 54 |
Interpretation Guide¶
| SDMA (µg/dL) | Interpretation |
|---|---|
| 0–14 | Normal |
| 14–18 | Borderline — recheck in 2–4 weeks |
| > 18 | Reduced GFR — pursue IRIS staging |
The Geriatric Advantage¶
In cachectic or geriatric patients, creatinine underestimates kidney disease (low muscle mass → low creatinine). SDMA is muscle-mass-independent, making it the more reliable marker in exactly the patients most at risk.
FAQ¶
When should I start SDMA screening? Annual screening in geriatric patients (dogs/cats > 7 years), or earlier with risk factors.
Does SDMA replace creatinine? No — they are complementary. SDMA detects early; creatinine contributes to IRIS staging and monitoring.
Case Study: The Geriatric Cat¶
A 12-year-old domestic shorthair presents for a routine senior wellness screen. No clinical signs; appetite and weight normal.
- Creatinine: 1.6 mg/dL (within reference).
- SDMA: 16 µg/dL (borderline; reference 0–14).
Interpretation: Creatinine is normal, but SDMA is borderline-elevated — a red flag that GFR may already be reduced. Recheck at 4 weeks: SDMA 19 µg/dL → IRIS Stage 2 CKD, prompting dietary and monitoring intervention before clinical signs.
Lesson: SDMA detected kidney disease that creatinine missed — in exactly the patient (geriatric) where early intervention matters most.
References¶
- Rafalska J, Rusiecka A, et al. Serum Creatinine, Cystatin C and Symmetric Dimethylarginine Concentrations and Relationship Between Them in Healthy Small and Miniature Dogs: A Preliminary Study. Animals (Basel). 2025;15(2):223. PMID: 41008005
For the review policy, see the Editorial & Review Policy.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-13
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.